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the SLGP, LSG and RSN were markedly increased by 1 hour inter-
mittent hypoxia.
(4) EMF reversed all these changes induced by 1 hour intermittent
hypoxia.
CONCLUSIONS EMF suppressed AF inducibility and the responses to
SLGP and LSG stimulation induced by intermittent hypoxia. Inhibition
of neural activities in the GP, LSG and RSN may be a mechanism
underlying these results.
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OBJECTIVES Acehytisine (previously named Guanfu base A), a novel
diterpene alkaloid isolated from the root of aconitum coreanum
(Levl.) raipaics which has been shown to effectively terminate AF and
supraventricular tachycardia in patients and animal models by
blocking multi-ion channels, but its effects on cellular electro phar-
macological activities of sodium channels are largely unknown in
atrial myocytes.
METHODS Primary atrial myocytes were isolated and cultured from
neonatal Sprague-Dawley rats (born 1-2 days). A single-pipette whole-
cell patch-clamp was used to investigate the acute effect of acehyti-
sine on sodium channels, and RT-PCR and western blot were used to
quantify a and b-subunits mRNA and protein expression implied
chronic effect on sodium channels.
RESULTS Atrial myocytes were cultured and plated into coverlips at
1104/cm2. 48h later, single cell was ruptured and INa was recorded in
absence and presence of acehytisine. It inhibited INa in a positive rate-
dependent and concentration-dependent manner, with IC50 value of
31.675.47mmol/L. 50mmol/L acehytisine signiﬁcantly shifted inacti-
vation curves toward left and shifted activation curves to right, but
did not modify the recovery kinetics from inactivation of sodium
channels. In addition, incubation with 100mmol/L acehytisine for
3-24h caused signiﬁcant decreases of a and b-subunits mRNA in time-
dependent manner (SCN5A decreased by 72.2418.21%, SCN1B
decreased by 52.8119.77%, SCN3B decreased by 83.4235.16% at 24h,
p <0.01 vs. untreated cells). Meanwhile, the quaniﬁcation of protein
levels was consistent with alteration of mRNA expression.
CONCLUSIONS These ﬁndings indicate that acehytisine inhibits sodium
channels by two modes, 1) inhibiting INa by binding to sodium channels
and 2) downregulating a and b-subunits at mRNA and protein levels,
which provides experimental evidence for anti-arrhythmia by acehytisine.GW26-e2401
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OBJECTIVES The deregulation of microRNAs (miRNAs), a class of
short and small non-coding RNAs, has been shown to be involved in a
wide range of cellular processes and cardiovascular pathologies. The
Apelin/APJ system has been implicated in the pathophysiology effects
in cardiovascular system, which is a necessary process in the initiation
and development of various cardiovascular diseases inclusive of
hypertension. We hypothesized that Apelin is a negative regulator
of hypertension-mediated pathological effects in spontaneously
hypertensive rats (SHR) model.
METHODS The 3-month-old male SHR and Wistar-Kyoto (WKY) rats
were obtained from Slac Laboratory Animal Co. Ltd. in China. Rats
received daily administration of Apelin or saline for 4 weeks. Systolic
blood pressure (SBP) of rat was measured by the tail-cuff method.
Vascular morphological analysis was processed using the computerimage analysis software for the quantiﬁcation of the media thickness
(MT), lumen diameter (LD), and the ratio of MT to LD, markers of
vascular hypertrophy and remodeling.
RESULTS In the SHR model, the aortic expression of miR-122-5p and
let-7b-3p were upregulated, while miR-1-3p, miR-376b-3p and miR-
298-5p were downregulated and negative correlated with SBP levels.
Compared with WKY rats, the MT and the MT/LD ratio of the thoracic
aorta were signiﬁcantly enhanced in SHR [MT: (127.24.5 um)
vs.(81.83.9 um); MT/LD ratio:(7.31.1) vs.(4.81.0); P<0.01, respec-
tively]. These changes were linked with the reduction of Apelin
expression and increased levels of ANF, and phosphorylated ERK1/2
as well as severe ultrastructural damage of the thoracic aorta. These
effects were signiﬁcantly blunted by Apelin treatment, in association
with a lowering of phosphorylated ERK1/2 levels and improvement of
ultrastructural injury. However, there were no changes in aortic
expression of APJ receptor among groups.
CONCLUSIONS There are abnormal levels of miRNAs and Apelin in
hypertensive status. In addition, Apelin is an important negative
regulator of the hypertension-induced pathological hypertrophy and
aortic remodeling and attenuates aortic ultrastructural injury in hy-
pertensive rats. These observations indicate that various miRNAs and
Apelin signaling in vasculature may be linked with hypertension and
provide novel pharmacologic implications for the prevention and
treatment of hypertension.
This work was supported by Training Program of the National Major
Research Plan (91339108), the National Basic Research Program of
China (2014CB542300), and the National Natural Science Foundation
of China (81370362 & 81170246).
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OBJECTIVES Reduced expression of Sarcoplasmic reticulum calcium-
transporting ATPase isoform 2a (SERCA2a) has been shown to play a
signiﬁcant role in the cardiac dysfunction of obese animal models. It
was reported recently that SUMOylation enhances the stability and
activity of SERCA2a. We hypothesized that SERCA2a-SUMOylation
might be involved in obesity-mediated reduction of SERCA2a.
METHODS Trimetazidine (TMZ), the drug that inhibits fatty acid
oxidation, was used in diet-induced obesity (DIO) rats and palmitic
acid (PA)-treated cardiomyocytes. The intensity of SERCA2a-SUMOy-
lation and proteins involved in SERCA2a-SUMOylation were investi-
gated in vivo and in vitro.
RESULTS DIO rats presented cardiac dysfunction, which was allevi-
ated by TMZ treatment. Reductions of SERCA2a protein and the
intensity of SERCA2a-SUMOylation were observed in DIO rats and
PA-treated cardiomyocytes. These reductions were partially restored
by TMZ. However, TMZ itself did not alter the intensity of SERCA2a-
SUMOylation in control cardiomyocytes. The variations of protein and
mRNA levels of Ubc9 are in accordance with the intensity of SERCA2a-
SUMOylation. Whereas the other proteins involved in SERCA2a-
SUMOylation were not changed by DIO and PA.
CONCLUSIONS TMZ alleviates the DIO-induced and PA-induced
reductions of SERCA2a-SUMOylation. Ubc9 is involved in the reductions.
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OBJECTIVES Vascular calciﬁcation (VC) is a highly regulated process in
which inﬂammatory cells inﬁltration and the factors controlling bone
mineralization are involved. This study aims to examine whether
osteopontin (OPN) and osteoprotegerin (OPG) exert effects in hyper-
tensive subjects with VC by regulating monocyte/macrophage activation.
METHODS We recruited 70 hypertensive subjects with or without
VC by artery electronic calculator tomography, peripheral blood
monocytes (CD14þ) and primary cultured macrophages were detected
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blood vessel samples was performed.
RESULTS Hypertensive subjects with VC had higher serum OPN and
OPG levels compared to these without VC, and their expressions
were also increased in the calciﬁc vessels (P <0.05). Interestingly, the
inﬂammatory factors from hypertensive patients with VC were
signiﬁcantly increased in cultured macrophages (P <0.05), and were
regulated by OPN and OPG.
CONCLUSIONS These ﬁndings provided a novel insight that OPN and
OPG-mediated inﬂammatory factors expression in macrophages were
involved in the processes of VC in hypertensive patients.
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OBJECTIVES Multiple unbiased genome-wide wide association studies
have identiﬁedastrong linkbetween9p21.3 locus andatheroscleroticdisease
risk. However, the direct mechanism accounting for the 9p21.3 CAD (Coro-
nary Artery Disease) risk still remains poorly understood and controversial.
Previous work including ours demonstrated that altered expression INK4/
ARF locus by non-coding RNA ANRILmight contribute to the 9p21.3 genetic
atherosclerosis susceptibility. Studies from other groups also suggested
possible physical interaction among 9p21.3, INK4/ARF locus and type I IFN
gene cluster. However, recent study has showed that 9p21 locus does not
affect risk of coronary artery disease through direct induction of type I IFNs.
METHODS To investigate whether type I IFN is co-regulated with
INK4/ARF and contributes to clinical onset of CAD in Han Chinese, we
ﬁrst examined the relationship of IFN subtypes with 9p21.3 variants in
170 healthy individuals in US, followed by plasma IFNa21 measure-
ment in 300 Han Chinese with CAD of different severity.
RESULTS We found that mRNA expression of IFNa21 correlated with
the expression of ARF and cANRIL, as well as rs10757278 CAD risk
allele. The expression of IFNa21 did not correlate with CAD severity
quantiﬁed by coronary angiography but was associated with the age of
CAD onset in Han Chinese.
CONCLUSIONS These data suggest that type I IFNs does not
contribute to CAD severity but may play a role in the age of onset of
CAD, possibly through an ANRIL-mediated co-regulatory mechanism
with INK4/ARF locus.
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OBJECTIVES The aim of this study was to combine clinical criteria
and next-generation sequencing (pyrosequencing) to establish a
diagnosis of familial hypercholesterolemia (FH).
METHODS A total of 39 subjects with a Dutch Lipid Clinic Network
score of 8 (deﬁnite FH clinical diagnosis) were recruited from the
Lipid Clinic at Anzhen Hospital, Beijing, China. Next-generation
sequencing was performed in all subjects using a GenCap Custom
Enrichment Kit (MyGenostics, Beijing, China), a kit that detects in 167
disease genes, relevant with blood lipids and cholic acid metabolism,
including low-density lipoprotein receptor (LDLR), apolipoprotein B
(APOB), proprotein convertase subtilisin/kexin type 9 (PCSK9) 3
known FH-causing genes.
RESULTS A total of 24 mutations were detected in 39 subjects.
Amongst these, 19 mutations were in the LDLR gene, three in the
APOB gene and two in the PCSK9 gene. We also found 151 SNPs and 69
genes relevant with blood lipids. Of these, 40 high frequency SNPs
and top 10 genes were summarized. The fourth, a mutation in LDLR
has not previously been reported; it was found to segregate with high
cholesterol levels in the family of the proband.
CONCLUSIONS Using a combination of clinical criteria and targeted
exome sequencing, we have achieved FH diagnosis with a high success
rate. Furthermore, we identiﬁed a new mutation in the LDLR gene.GW26-e2955
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OBJECTIVES Our previous study showed that decreased GPx-1 ac-
tivity in KD patients was associated with the GPx-1 Pro198Leu poly-
morphism and Se deﬁciency. The purpose of this study is to further
elucidate the association between different Se levels and the
GPx-1P198L.
METHODS GPx-1P198L transgenic mice (Tg) were generated and fed by
control diet (CON, 0.1-0.2mg Se/kg) or Se-deﬁcient diet (SD, <0.02 mg
Se/kg) for 12 weeks. Heart GPX-1 expression was detected by realtime
RT-PCR and western blot. Echocardiographic measurements were
performed to measure the cardiac function. Serum Se was analyzed by
a ﬂameless atomic absorption spectrophotometry method. Myocardial
GPx activity was spectrophotometrically measured using a cellular
glutathione peroxidase activity assay kit. Caspase-9 and 3 levels were
detected by western blot.
RESULTS In GPx-1P198L transgenic mice, heart GPx-1 expression was
remarkable upregulated when compared with wide type (WT) control
(P<0.05), whereas, GPx-1 activity showed no difference (P>0.05). Se
deﬁciency resulted in cardiac systolic dysfunction both in WT and Tg
mice and showed no difference (P>0.05). Se deﬁciency led to
myocardial ﬁbrosis accompanied by increased expression of caspase-9
and -3 In WT mice. But in Tg mice, expression levels of caspase-9 and
-3 were attenuated, whereas, myocardial ﬁbrosis was not signiﬁcantly
decreased.
CONCLUSIONS Overexpression of GPx-1P198L did not show evident
protection against cardiac remodeling and failure. These results
further documented that GPx-1P198L might be a functional poly-
morphism which may cause functional deﬁciency of GPx-1.GW26-e3821
Hypercholesterolemia abrogates the protective effect of ischemic
postconditioning by induction of apoptosis and impairment of activation
of reperfusion injury salvage kinase pathway
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OBJECTIVES Ischemic postcontioning (IPoC) is an effective method
to prevent myocardial ischemia reperfusion injury (MIRI), but its
cardioprotection is usually blocked in the presence of hypercholes-
terolemia (HC) and the potential mechanism is still unknown.
METHODS In this study, we investigated the roles of reperfusion
injury salvage kinase (RISK) and apoptosis-related pathways in the
attenuation of cardioprotection of IPoC in the presence of HC.
RESULTS The results showed that IPoC signiﬁcantly decreased the
infarct size and apoptosis, improved the recovery of ischemic
myocardium, but these beneﬁcial effects were reversed by high
cholesterol diet-induced HC. Moreover, we also found that HC
inhibited the phosphorylation of Akt and ERK1/2 which usually acti-
vated by IPoC in normal heart, induced excessive apoptosis by down-
regulating Bcl-2 and up-regulating Bax, cytochrome c, caspase 9 and
caspase 3 when compared with that in normal heart.
CONCLUSIONS Taken together, our results demonstrated that the
cardioprotection of IPoC was abolished by HC, which was associated
with inactivation of RISK signal pathway and dysregulation of
downstream apoptosis-related pathway.
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OBJECTIVES Brugada syndrome (BrS) is a clinical entity with high
incidence of sudden cardiac death. Diagnosis of BrS solely relies on
